Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Aeterna Zentaris Inc.
  6. Summary
    AEZS   CA0079754028

AETERNA ZENTARIS INC.

(AEZS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
01/14/2022 01/17/2022 01/18/2022 01/19/2022 01/20/2022 Date
0.465(c) 0.465(c) 0.43(c) 0.43(c) 0.43(c) Last
117 930 23 871 101 423 33 020 45 629 Volume
+2.20% 0.00% -7.53% 0.00% 0.00% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 2,42 M - -
Net income 2021 -7,95 M - -
Net Debt 2021 - - -
P/E ratio 2021 -4,91x
Yield 2021 -
Sales 2022 3,52 M - -
Net income 2022 -13,9 M - -
Net Debt 2022 - - -
P/E ratio 2022 -3,13x
Yield 2022 -
Capitalization 41,7 M 41,9 M -
Capi. / Sales 2021 17,3x
Capi. / Sales 2022 11,9x
Nbr of Employees 12
Free-Float -
More Financials
Company
Aeterna Zentaris Inc. is a specialty biopharmaceutical company. The Company is focused on developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. Its business strategy is to finalize the development, manufacturing, registration and commercialization of Macrilen (macimorelin). Macrilen (macimorelin) is an orally available... 
Sector
Biotechnology & Medical Research
Calendar
01/26 | 09:00amPresentation
More about the company
All news about AETERNA ZENTARIS INC.
01/20Aeterna Zentaris to Present at the Virtual Investor 2022 Top Picks Conference
AQ
01/05Aeterna Zentaris to Present at the H.C. Wainwright BioConnect Conference
GL
01/05Aeterna Zentaris to Present at the H.C. Wainwright BioConnect Conference
GL
2021AETERNA ZENTARIS : Appoints Giuliano La Fratta as Chief Financial Officer - Form 6-K
PU
2021Aeterna Zentaris Names Giuliano La Fratta as CFO
MT
2021AETERNA ZENTARIS BRIEF : Appoints Giuliano La Fratta as Chief Financial Officer
MT
2021Aeterna Zentaris Appoints Giuliano La Fratta as Chief Financial Officer
AQ
2021Aeterna Zentaris Appoints Giuliano La Fratta as Chief Financial Officer
CI
2021Aeterna Zentaris Appoints Giuliano La Fratta as Chief Financial Officer
CI
2021AEterna Zentaris Q3 Loss Widens on Higher Research and Development Costs
MT
2021Aeterna Zentaris Inc. Reports Earnings Results for the Third Quarter and Nine Months En..
CI
2021Aeterna Zentaris Reports Third Quarter 2021 Financial Results and Provides Pipeline Pro..
AQ
2021AETERNA ZENTARIS : HC Wainwright Starts AEterna Zentaris at Buy With $2 Price Target
MT
2021AETERNA ZENTARIS : to Present at the H.C. Wainwright 23rd Annual Global Investment Confere..
PU
2021AETERNA ZENTARIS : to Present at the H.C. Wainwright 23rd Annual Global Investment Confere..
AQ
More news
News in other languages on AETERNA ZENTARIS INC.
2021Aeterna Zentaris nomme Giuliano La Fratta au poste de directeur financier
2021La perte d'AEterna Zentaris au troisième trimestre se creuse en raison de l'augmentatio..
2021Aeterna Zentaris engage un spécialiste de la recherche pour contribuer au développement..
2021Aeterna Zentaris, société à double cotation, augmente de 1,2 % avant sa mise sur le mar..
2021Aeterna Zentaris entame le développement préclinique de Macimorelin à l'Université du Q..
More news
Analyst Recommendations on AETERNA ZENTARIS INC.
More recommendations
Chart AETERNA ZENTARIS INC.
Duration : Period :
Aeterna Zentaris Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AETERNA ZENTARIS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 0,43 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Klaus Wolfgang Paulini President, Chief Executive Officer & Director
Leslie Auld Chief Financial Officer & Senior Vice President
Carolyn Egbert Non-Executive Chairman
Michael Teifel Chief Scientific Officer
Nicola Ammer Chief Medical Officer & VP-Clinical Development
Sector and Competitors
1st jan.Capi. (M$)
AETERNA ZENTARIS INC.-5.49%42
MODERNA, INC.-31.46%70 577
LONZA GROUP AG-14.10%53 088
IQVIA HOLDINGS INC.-14.84%45 903
SEAGEN INC.-14.26%24 238
ICON PUBLIC LIMITED COMPANY-17.00%20 923